4.0 Review

Post COVID-19 pulmonary fibrosis; a meta-analysis study

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia

Xiaoyu Han et al.

Summary: The study found that over one-third of severe COVID-19 patients showed fibrotic-like changes in the lung at 6-month follow-up CT, which were associated with older age, acute respiratory distress syndrome, longer hospital stays, tachycardia, noninvasive mechanical ventilation, and higher initial chest CT score.

RADIOLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Thin-section computed tomography findings and longitudinal variations of the residual pulmonary sequelae after discharge in patients with COVID-19: a short-term follow-up study

Die Zhang et al.

Summary: This study analyzed and compared CT findings and longitudinal variations after discharge in severe and non-severe COVID-19 patients, showing significant differences in the characteristics and changing trends of pulmonary sequelae between the two groups. Patients with severe/critical disease had more serious pulmonary sequelae and slower recovery compared to those with moderate disease. Some fibrosis-like findings were completely absorbed in patients with moderate and severe/critical diseases after discharge.

EUROPEAN RADIOLOGY (2021)

Article Multidisciplinary Sciences

The characteristics and evolution of pulmonary fibrosis in COVID-19 patients as assessed by AI-assisted chest HRCT

Jia-Ni Zou et al.

Summary: The study using AI-assisted chest HRCT revealed the incidence, characteristics, risk factors, and evolution of pulmonary fibrosis in patients with COVID-19. Patients with severe or critical COVID-19 had a higher risk of pulmonary fibrosis, but with time, most patients showed improvement or resolution of pulmonary fibrosis.

PLOS ONE (2021)

Article Respiratory System

Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length

Claire F. McGroder et al.

Summary: Patients who underwent mechanical ventilation for severe COVID-19 are more likely to develop fibrotic-like radiographic abnormalities after hospitalisation. The severity of initial illness, duration of mechanical ventilation, lactate dehydrogenase on admission, and leucocyte telomere length are independent risk factors for these abnormalities, which are correlated with lung function, cough, and frailty measures, but not with dyspnoea.

THORAX (2021)

Review Surgery

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA 2020 statement, an updated version of the 2009 statement, includes new reporting guidance that reflects advances in research methods. This article introduces the PRISMA 2020 27-item checklist and related information.

INTERNATIONAL JOURNAL OF SURGERY (2021)

Letter Radiology, Nuclear Medicine & Medical Imaging

Fibrotic Interstitial Lung Abnormalities at 1-year Follow-up CT after Severe COVID-19

Xiaoyu Han et al.

RADIOLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Post-COVID-19 pulmonary fibrosis and its predictive factors: a prospective study

Mehrdad Nabahati et al.

Summary: This study found that about half of COVID-19 survivors developed lung fibrosis, with severe patients at higher risk. Additionally, consolidation and higher CSS in the initial CT scan were associated with an increased risk of post-COVID-19 lung fibrosis. In the 6-month follow-up, some patients showed diminished fibrotic abnormalities while others did not.

EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE (2021)

Article Respiratory System

Pulmonary fibrosis and its related factors in discharged patients with new corona virus pneumonia: a cohort study

Xiaohe Li et al.

Summary: Older age, higher BMI, severe/critical condition, fever, longer viral clearance time, pre-existing disease, and delayed hospitalization were identified as risk factors for developing persistent pulmonary fibrosis in COVID-19 patients. About one-third of fibrotic patients could reverse their condition after around 120 days from onset, and less than half of the patients had their lung function return to normal condition after three months from onset. An effective predictive model with an average AUC of 0.84 was established for early diagnosis of the persistence of pulmonary fibrosis in COVID-19 patients.

RESPIRATORY RESEARCH (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Post-COVID-19 pneumonia lung fibrosis: a worrisome sequelae in surviving patients

Rasha Mostafa Mohamed Ali et al.

Summary: This study aimed to identify potential cases of post-COVID-19 pulmonary fibrosis early in order to prevent or modify such disabling complications, with factors like old age, cigarette smoking, high CT severity score, and long-term mechanical ventilation being potential predictors of lung fibrosis.

EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Predicting lung fibrosis in post-COVID-19 patients after discharge with follow-up chest CT findings

Rabab Yasin et al.

Summary: This study assessed the clinical, radiographic, and laboratory findings of COVID-19 patients with HRCT follow-up after discharge, aiming to predict lung fibrosis in survivors. Factors such as age, CT severity, consolidation/crazy-paving scores, and ICU admission were identified as independent risk factors associated with post-COVID-19 fibrosis in survivors.

EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE (2021)

Article Respiratory System

Persistent Post-COVID-19 Interstitial Lung Disease An Observational Study of Corticosteroid Treatment

Katherine Jane Myall et al.

Summary: Following SARS-CoV-2 infection, some patients develop persistent radiological inflammatory lung disease and functional deficits. Early treatment with corticosteroids is well tolerated and associated with rapid and significant improvement.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)

Editorial Material Critical Care Medicine

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

Haibo Zhang et al.

INTENSIVE CARE MEDICINE (2020)

Article Critical Care Medicine

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy

Peter M. George et al.

LANCET RESPIRATORY MEDICINE (2020)

Review Critical Care Medicine

Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations

Jason Phua et al.

LANCET RESPIRATORY MEDICINE (2020)

Editorial Material Immunology

SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis

M. Victoria Delpino et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

Letter Medicine, General & Internal

Persistent Symptoms in Patients After Acute COVID-19

Angelo Carfi et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Large vessel thrombosis in patient with COVID-19, a case series

Aram Baram et al.

ANNALS OF MEDICINE AND SURGERY (2020)

Article Medicine, General & Internal

Severe refractory COVID-19 patients responding to convalescent plasma; A case series

Hadi Mohammed Abdullah et al.

ANNALS OF MEDICINE AND SURGERY (2020)